Precision BioSciences
DTIL
69 hedge funds and large institutions have $62.8M invested in Precision BioSciences in 2025 Q4 according to their latest regulatory filings, with 21 funds opening new positions, 22 increasing their positions, 7 reducing their positions, and 8 closing their positions.
214% more repeat investments, than reductions
Existing positions increased: 22 | Existing positions reduced: 7
163% more first-time investments, than exits
New positions opened: 21 | Existing positions closed: 8
145% more capital invested
Capital invested by funds: $25.7M → $62.8M (+$37.2M)
74.51% more ownership
Funds ownership: 39.45% → 113.95% (+75%)
23% more funds holding
Funds holding: 56 → 69 (+13)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $1K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Aberdeen Group
Edinburgh,
United Kingdom
|
+$12.1M |
| 2 |
OCA
Octagon Capital Advisors
New York
|
+$10.9M |
| 3 |
BFM
Boothbay Fund Management
New York
|
+$5.04M |
| 4 |
Alyeska Investment Group
Chicago,
Illinois
|
+$4.53M |
| 5 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
+$4.47M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TCM
Tang Capital Management
San Diego,
California
|
-$3.61M |
| 2 |
Acadian Asset Management
Boston,
Massachusetts
|
-$358K |
| 3 |
TC
Tejara Capital
London,
United Kingdom
|
-$324K |
| 4 |
LCM
Lynx1 Capital Management
San Juan,
Puerto Rico
|
-$276K |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
-$113K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
76
Zurich Cantonal Bank
Zurich,
Switzerland
| – | -$381 | -69 | Closed |
|
DTIL Hedge Fund Activity: Q4 2025 in Review
69 of the 8,223 institutional investors tracked by Wall St. Rank reported a position in Precision BioSciences (DTIL) for Q4 2025, worth a combined $62.8M — up 145% from $25.7M a quarter earlier.
Buyers outnumbered sellers: 21 funds opened new DTIL positions and 8 closed out — a net gain of 13 holders — while 22 added to existing stakes and 7 trimmed.
The largest buyer was Aberdeen Group, opening a new position worth an estimated $12.1M. The largest seller was Tang Capital Management, exiting entirely with an estimated $3.61M sold.
- 69 institutional investors held Precision BioSciences (DTIL) as of Q4 2025, up from 56 in Q3 2025.
- Funds reported $62.8M of Precision BioSciences stock for Q4 2025, up 145% quarter-over-quarter.
- 21 funds opened new Precision BioSciences positions in Q4 2025 and 8 closed out, a net change of +13 holders.
- The largest Precision BioSciences buyer in Q4 2025 was Aberdeen Group, an estimated $12.1M added.
- The largest Precision BioSciences seller in Q4 2025 was Tang Capital Management, an estimated $3.61M sold.
Based on aggregated 13F filings for Q4 2025.